ClinicalTrials.Veeva

Menu

Immediate Breast Reconstruction With Acellular Dermal Matrix

A

Aarhus University Hospital

Status

Completed

Conditions

Breast Cancer
Breast Carcinoma in Situ
Mammaplasty
Acellular Dermis

Treatments

Procedure: one-stage technique

Study type

Observational

Funder types

Other

Identifiers

NCT04209010
VEK 1-10-72-572-12

Details and patient eligibility

About

The aim of this study is to contribute to the knowledge regarding immediate implant-based BR by investigating whether the one-stage technique with ADM is superior to the two-stage expander to implant technique. Primary endpoint in first publication is postoperative complications, secondary endpoint is patient and investigator assessed aesthetic outcome. Primary endpoint in second publication is cost, secondary endpoint is patient reported outcome measures.

Enrollment

44 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Skin sparing mastectomy due to breast cancer, ductal carcinoma in situ or high genetic risk of developing breast cancer
  • Mastectomy weight ≤ 600 g
  • Patient older than 18 years
  • Ability to complete the study questionnaire
  • Only for the two-stage group no later than 2 years and 4 months from breast reconstruction

Exclusion criteria

  • smokers

Trial design

44 participants in 2 patient groups

One-stage group
Description:
Immediate implant based breast reconstruction after skin sparing mastectomy in one stage using silicone implant and acellular dermal matrix.
Treatment:
Procedure: one-stage technique
Two-stage group
Description:
Immediate implant based breast reconstruction after skin sparing mastectomy in two stages using expander to silicone implant technique.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems